Elisabeth SOUHAMI

Person

Les Pavillons sous Bois, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Insulin glargine/lixisenatide fixed ratio formulation
- Patent number 12,186,374
- Issue date Jan 7, 2025
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Insulin glargine/lixisenatide fixed ratio formulation
- Patent number 11,026,999
- Issue date Jun 8, 2021
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment type 2 diabetes mellitus patients
- Patent number 10,434,147
- Issue date Oct 8, 2019
- Sanofi-Aventis Deutschland GmbH
- Christine Roy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Insulin glargine/lixisenatide fixed ratio formulation
- Patent number 9,950,039
- Issue date Apr 24, 2018
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20250177487
- Publication date Jun 5, 2025
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20250064898
- Publication date Feb 27, 2025
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20230037934
- Publication date Feb 9, 2023
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20220031811
- Publication date Feb 3, 2022
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20210128692
- Publication date May 6, 2021
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF TYPE 2 DIABETES MELLITUS
- Publication number 20210093698
- Publication date Apr 1, 2021
- SANOFI
- Elisabeth NIEMÖLLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20200038488
- Publication date Feb 6, 2020
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20190381145
- Publication date Dec 19, 2019
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin Glargine/Lixisenatide Fixed Ratio Formulation
- Publication number 20190060411
- Publication date Feb 28, 2019
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin glargine/lixisenatide fixed ratio formulation
- Publication number 20180133290
- Publication date May 17, 2018
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment Type 2 Diabetes Mellitus Patients
- Publication number 20180092965
- Publication date Apr 5, 2018
- Sanofi-Aventis Deutschland GmbH
- Christine Roy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO...
- Publication number 20170136094
- Publication date May 18, 2017
- Sanofi-Aventis Deutschland GmbH
- Louise SILVESTRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment Type 2 Diabetes Mellitus Patients
- Publication number 20160287674
- Publication date Oct 6, 2016
- Sanofi-Aventis Deutschland GmbH
- Christine Roy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin glargine/lixisenatide fixed ratio formulation
- Publication number 20160199452
- Publication date Jul 14, 2016
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin glargine/lixisenatide fixed ratio formulation
- Publication number 20140371141
- Publication date Dec 18, 2014
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT PROTOCOL OF DIABETES TYPE 2
- Publication number 20130296236
- Publication date Nov 7, 2013
- Louise SILVESTRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO...
- Publication number 20110118178
- Publication date May 19, 2011
- Sanofi-Aventis Deutschland GmbH
- Louise SILVESTRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Elisabeth SOUHAMI

Person

Patents Grantslast 30 patents

Insulin glargine/lixisenatide fixed ratio formulation

Insulin glargine/lixisenatide fixed ratio formulation

Treatment type 2 diabetes mellitus patients

Insulin glargine/lixisenatide fixed ratio formulation

Patents Applicationslast 30 patents

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

TREATMENT OF TYPE 2 DIABETES MELLITUS

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

Insulin Glargine/Lixisenatide Fixed Ratio Formulation

Insulin glargine/lixisenatide fixed ratio formulation

Treatment Type 2 Diabetes Mellitus Patients

METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO...

Treatment Type 2 Diabetes Mellitus Patients

Insulin glargine/lixisenatide fixed ratio formulation

Insulin glargine/lixisenatide fixed ratio formulation

TREATMENT PROTOCOL OF DIABETES TYPE 2

METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO...